Safety and efficacy of transcatheter arterial micro embolization (TAME) using Imipenem / Cilastatin (IPM/CS) for chronic musculoskeletal pain refractory to non-surgical management.
Not Applicable
- Conditions
- Musculoskeletal chronic pain refractory to non-surgical management(Glenohumeral joint, elbow joint, hip joint and knee joint)
- Registration Number
- JPRN-UMIN000026094
- Lead Sponsor
- Tottori university, Faculty of medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 20
Inclusion Criteria
Not provided
Exclusion Criteria
1)Adaptation of treating surgically. 2)Neoplasm 3)Severe arteriosclerosis 4)Pregnant female, female with the possibility of the pregnancy or nursing female 5)6)Iodine Allergy 7)IPM/CS Allergy 8)Using sodium valproate 9)Patients with the past of hypersensitivity for carbapenem system, penicillin system or cephem antibiotics. 10)Severe depression 11)Uncontrollable severe diabetes mellitus 12)Patients who have difficulty in going to hospital follow-up after this treatment enforcement. 13)Patients who abnormal vessels are not recognized in an angiography.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method umerical Rating Scale(NRS)of pain.
- Secondary Outcome Measures
Name Time Method Feasibility of TAME. Region of joint. QOL using EQ5D. Imaging of MRI.